URSODEOXYCHOLIC ACID
SEPSIS
University of OxfordSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the SEPSIS cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NORMAL HUMAN SERUM ALBUMIN Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | BB |
Midodrine Hospital Clinic of Barcelona | Phase 4 | BB |
SIMVASTATIN Hospital General de Mexico | Phase 4 | BB |
Gm-Csf National Cancer Institute (NCI) | Phase 3 | B |
Noradrenaline Indonesia University | Phase 2/3 | B |
View all 26 →
Same molecule, other indications
URSODEOXYCHOLIC ACID is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →